New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania

References

• KleinmanLLowinAFloodECosts of bipolar disorderPharmacoeconomics20032160162212807364
   PubMed Web of Science ®Google Scholar
• MerikangasKRJinRHeJ-PPrevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey InitiativeArch Gen Psychiatry20116824125121383262
   PubMed Web of Science ®Google Scholar
• JansenKda Costa OresLde Azvedo CardosoTPrevalence of episodes of mania and hypomania and associated comorbidities among young adultsJ Affective Disord2011130328333
   PubMed Web of Science ®Google Scholar
• HirschfeldRMCassARHoltDCCarlsonCAScreening for bipolar disorder in patients treated for depression in a family medicine clinicJ Am Board Fam Pract20051823323915994469
   PubMedGoogle Scholar
• DasAKOlfsonMGameroffMJScreening for bipolar disorder in a primary care practiceJAMA200529395696315728166
   PubMed Web of Science ®Google Scholar
• OlfsonMDasAKGameroffMJBipolar depression in a low-income primary care clinicAm J Psychiatry20051622146215116263856
   PubMed Web of Science ®Google Scholar
• ShiLThiebaudPMcCombsJSThe impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) programJ Affect Disord20048237338315555688
   PubMed Web of Science ®Google Scholar
• DubovskySLLeonardKGriswoldKBipolar disorder is common in depressed primary care patientsPostgraduate Medicine201112312913321904095
   PubMed Web of Science ®Google Scholar
• DilsaverSCAn estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009J Affective Disord20111297983
   PubMed Web of Science ®Google Scholar
• PiniSde QueirozVPagninDPrevalence and burden of bipolar disorders in European countriesEur Neuropsychopharmacol20051442543415935623
   PubMed Web of Science ®Google Scholar
• DunnerDLClinical consequences of under-recognized bipolar spectrum disorderBipolar Disord2003545646314636371
   PubMed Web of Science ®Google Scholar
• JuddLLAkiskalHSThe prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold casesJ Affective Disord200373133146
   Web of Science ®Google Scholar
• BauerMPfennigAEpidemiology of bipolar disordersEpilepsia200546
   Web of Science ®Google Scholar
• WeissmanMMBlandRCCaninoGJCross-national epidemiology of major depression and bipolar disorderJAMA19962762932998656541
   PubMed Web of Science ®Google Scholar
• GrantBFStinsonFSHasinDSPrevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related ConditionsJ Clin Psychiatry2005661205121516259532
   PubMed Web of Science ®Google Scholar
• AkiskalHSThe prevalent clinical spectrum of bipolar disorders: Beyond DSM-IVJ Clin Psychopharmacology199616Suppl 24S14S
   Web of Science ®Google Scholar
• AngstJAzorinJMBowdenCLPrevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episodeArch Gen Psychiatry20116879179921810644
   PubMed Web of Science ®Google Scholar
• AkiskalHSBourgeoisMLAngstJRe-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disordersJ Affective Disord200059Suppl 1S5S30
   PubMed Web of Science ®Google Scholar
• AngstJGammaABenazziFToward a re-definition of sub-threshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomaniaJ Affective Disord200373133146
   PubMed Web of Science ®Google Scholar
• AngstJCuiLSwendsenJMajor depressive disorder with subthreshold bipolarity in the National Comorbidity Survey ReplicationAm J Psychiatry20101671194120120713498
   PubMed Web of Science ®Google Scholar
• MerikangasKRAkiskalHSAngstJLifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replicationArch Gen Psychiatry20076454355217485606
   PubMed Web of Science ®Google Scholar
• SachsGSNierenbergAACalabreseJREffectiveness of adjunctive antidepressant treatment for bipolar depressionN Engl J Med20073561711172217392295
   PubMed Web of Science ®Google Scholar
• GhaemiSNHsuDJSoldaniFGoodwinFKAntidepressants in bipolar disorder: the case for cautionBipolar Disord2003542143314636365
   PubMed Web of Science ®Google Scholar
• SchneckCDMiklowitzDJMiyaharaSThe prospective course of rapid cycling bipolar disorder: findings from the STEP-BDAm J Psychiatry200816537037718198271
   PubMed Web of Science ®Google Scholar
• BauerMMitchnerLWhat is a “mood stabilizer”? An evidence-based responseAm J Psychiatry200416131814702242
   PubMed Web of Science ®Google Scholar
• EttingerABPsychotropic effects of antiepileptic drugsNeurology2006671916192517159095
   PubMed Web of Science ®Google Scholar
• McElroySLKeckPEStantonSPA randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic maniaJ Clin Psychiatry1996571421468601548
   PubMed Web of Science ®Google Scholar
• OkumaTYamashitaITakahashiRComparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled studyPharmacopsychiatry1990231431501973844
   PubMed Web of Science ®Google Scholar
• KramlingerKGPostRMThe addition of lithium to carbamazepine: antidepressant efficacy in treatment-resistant depressionArch Gen Psychiatry1989467948002505730
   PubMed Web of Science ®Google Scholar
• WeislerRHHirschfeldRCutlerAJExtended-release carbamazepine capsules as monotherapy in bipolar disorder: pooled results from two randomised, double-blind, placebo-controlled trialsCNS Drugs20062021923116529527
   PubMed Web of Science ®Google Scholar
• PopovicDReinaresMAmannBSalameroMVietaENumber needed to treat analyses of drugs used for maintenance treatment of bipolar disorderPsychopharmacology201121365766721052983
   PubMed Web of Science ®Google Scholar
• KimEYouMPikalovAVan-TranQJingYOne-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysisBMC Psychiatry201111621214937
   PubMed Web of Science ®Google Scholar
• McIntyreRSBrecherMPaulssonBHuizarKMullenJQuetiapine or haloperidol as monotherapy for bipolar mania-a 12-week, double-blind, randomised, parallel-group, placebo controlled trialEur Neuropsychopharmacol20051557358516139175
   PubMed Web of Science ®Google Scholar
• DubovskySLClinical Guide to Psychotropic MedicationsNew YorkWW Norton2005
   Google Scholar
• TohenMCalabreseJRSachsGRandomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapineAm J Psychiatry200616324725616449478
   PubMed Web of Science ®Google Scholar
• AlvarezPAPahissaJQT alterations in psychopharmacology: proven culprits and suspectsCurr Drug Saf201059710420210726
   PubMedGoogle Scholar
• American Diabetes AssociationAmerican Psychiatric AssociationAmerican Association of Clinical EndocrinologistsNorth American Association for the Study of ObesityConsensus development conference on antipsychotic drugs and obesity and diabetesDiabetes Care20042759660114747245
   PubMed Web of Science ®Google Scholar
• EdwardsSJSmithCJTolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trialsClin Ther200931Pt 11345135919698898
   PubMed Web of Science ®Google Scholar
• GothelfDFalkBSingerPWeight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapineAm J Psychiatry20021591055105712042200
   PubMed Web of Science ®Google Scholar
• HeinrichTWBibloLASchneiderJTorsades de pointes associated with ziprasidonePsychosomatics20064726426816684946
   PubMed Web of Science ®Google Scholar
• HennessySBilkerWBKnaussJSCardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative dataBMJ2002325107110
   Web of Science ®Google Scholar
• CoryellWEndicottJMaserJDThe likelihood of recurrence in bipolar affective disorder: the importance of episode recencyJ Affect Disord1995332012067790673
   PubMed Web of Science ®Google Scholar
• GallagherPMalikNNewhamJAntiglucocorticoid treatments for mood disordersCochrane Database Syst Rev20082134
   Google Scholar
• GitlinMTreatment resistant bipolar disorderMol Psychiatry20061122724016432528
   PubMed Web of Science ®Google Scholar
• KowatchRASethuramanGHumeJHKromelisMWeinbergWACombination pharmacotherapy in children and adolescents with bipolar diosrderBiol Psychiatry20035397898412788243
   PubMed Web of Science ®Google Scholar
• PostRMAltshulerLFryeMRate of switch in bipolar patients prospectively treated with second generation antidepressants as augmentation to mood stabilizersBipolar Disord2001325926511912569
   PubMed Web of Science ®Google Scholar
• RybakowskiJKBipolarity and inadequate response to antidepressant drugs: clinical and psychopharmacological perspectiveJ Affective Disord2012136e13e19
   PubMed Web of Science ®Google Scholar
• BowdenCLVietaEIceKSZiprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trialJ Clin Psychiatry20107113013720122373
   PubMed Web of Science ®Google Scholar
• TohenMChengappaKNSuppesTRelapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabilizer v. mood stabilizer aloneBr J Psychiatry200418433734515056579
   PubMed Web of Science ®Google Scholar
• VietaESuppesTEggensIEfficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorderJ Affective Disord2008109251263
   PubMed Web of Science ®Google Scholar
• ShahdidMWalkerGZornSAsenapine, a novel psychopharmacologic agent with a unique receptor signatureJ Psychopharmacol200923657318308814
   PubMed Web of Science ®Google Scholar
• ChwiedukCMScottLJAsenapine: a review of its use in the management of mania in adults with bipolar I diosrderCNS Drugs20112525126721323396
   PubMed Web of Science ®Google Scholar
• WeberJMcCormackPLAsenapineCNS Drugs20092378179219689168
   PubMed Web of Science ®Google Scholar
• MeyerJMPharmacotherapy of psychosis and maniaBruntonLLBlumenthalDMurriNHilal-DandanRGoodman and Gilman’s the Pharmacological Basis of Therapeutics12th edNew YorkMcGraw-Hill2012
   Google Scholar
• LiebermanJAStroupTSMcEvoyJPEffectiveness of antipsychotic drugs in patients with chronic schizophreniaN Engl J Med20053531209122316172203
   PubMed Web of Science ®Google Scholar
• McIntyreRSWongRAsenapine: a synthesis of efficacy data in bipolar mania and schizophreniaClin Schizophrenia Relat Psychoses20125217220
   PubMedGoogle Scholar
• BartlettJAMaarschalkKVUnderstanding the oral mucosal absorption and resulting clinical pharmacokinetics of asenapineAAPS PharmSciTech2012131110111522936407
   PubMed Web of Science ®Google Scholar
• GerritsMde GreefRPeetersPEffect of absorption site on the pharmacokinetics of sublingual asenapine in healthy male subjectsBiopharm Drug Dispos20103135135720549835
   PubMed Web of Science ®Google Scholar
• PanagidesJMcIntyreRSAlphsLAsenapine in acute mania: a randomized, double-blind, placebo- and olanzapine-controlled trialBiol Psychiatry200761Suppl 8222S223S
   Web of Science ®Google Scholar
• McIntyreRSCohenMZhaoJA 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed statesBipolar Disord20091167368619839993
   PubMed Web of Science ®Google Scholar
• McIntyreRSCohenMZhaoJAsenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trialJ Affective Disord20101222738
   PubMed Web of Science ®Google Scholar
• McIntyreRSCohenMZhaoJAsenapine versus olanzapine in acute mania: a double-blind extension studyBipolar Disord20091181582619832806
   PubMed Web of Science ®Google Scholar
• BaruchYTadgerSPlopskiIBarakYAsenapine for elderly bipolar manic patientsJ Affective Disord2013145130132
   PubMed Web of Science ®Google Scholar
• SzegediACalabreseJStetLAsenapine as adjunctive treatment for acute mania associated with bipolar disorder. Results of a 12-week core study and 40-week extensiionJ Clin Psychopharmacology2012324655
   PubMed Web of Science ®Google Scholar
• McIntyreRSCohenMZhaoJAsenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension studyJ Affective Disord2010126358365
   PubMed Web of Science ®Google Scholar
• De HertMYuWDetrauxJBody weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar diosrder: a systematic review and exploratory meta-analysisCNS Drugs20122673375922900950
   PubMed Web of Science ®Google Scholar
• PeetersPBockbraderHSpaansEAsenapine pharmacokinetics in hepatic and renal impairmentClin Pharmacokinet20115047148121651314
   PubMed Web of Science ®Google Scholar
• HenryJMFullerMAAsenapine: a new antipsychotic optionJ Pharm Pract20112444745122156709
   PubMedGoogle Scholar